What is the PLoS Hub for Clinical Trials?
The PLoS Hub for Clinical Trials collects PLoS journal articles that relate to clinical trials. The Hub is a site for researchers to share their views and build a dynamic, interactive community.
Currently, the PLoS Hub for Clinical Trials features articles originally published in PLoS Clinical Trials, along with clinical trials articles from PLoS ONE.
In the future, this new resource will expand to include articles from all the PLoS titles that publish clinical trials. It will also feature open-access articles from other journals plus user-generated content.
Recently Added Clinical Trials
- Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa
- Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria
- Are Child and Adolescent Responses to Placebo Higher in Major Depression than in Anxiety Disorders? A Systematic Review of Placebo-Controlled Trials
- Elevated Stress-Hemoconcentration in Major Depression Is Normalized by Antidepressant Treatment: Secondary Analysis from a Randomized, Double-Blind Clinical Trial and Relevance to Cardiovascular Disease
- Triacylglycerol Fatty Acid Composition in Diet-Induced Weight Loss in Subjects with Abnormal Glucose Metabolism – the GENOBIN Study
Browse Clinical Trials Articles: By Subject or By Publication Date
Highlights From Other Open Access Journals
Join the Community
Register now and share your views on clinical trials research. Only registrants can add Notes, Comments, and Ratings to articles in the Hub.
Submit Your Work
PLoS is committed to publishing the results of all clinical trials, regardless of outcome, and making this essential information freely and publicly available. Find out how to submit your work.
From the PLoS Blog
Read the PLoS Blog 
and contribute your views on scientific research and open-access publishing.
From the Web
HealthBeat blog: Senators Baucus and Kent Introduce Bill to Create a Comparative Effectiveness Institute
